Citigroup’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
259,142
-51,772
-17% -$2.09M ﹤0.01% 1602
2026
Q1
$13.8M Buy
310,914
+163,598
+111% +$7.22M 0.01% 1276
2025
Q4
$6.19M Buy
+147,316
New +$6.22M ﹤0.01% 1865

Other funds holding MDLN

Citigroup's MDLN Position: Q2 2026 in Review

Citigroup reduced its Medline Inc (MDLN) stake by 17% in Q2 2026, selling an estimated $2.09M and leaving 259,142 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Citigroup first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.8M in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Citigroup held 259,142 shares of Medline Inc worth $10.2M as of Q2 2026.
  • Citigroup sold 51,772 Medline Inc shares in Q2 2026, an estimated $2.09M.
  • Medline Inc made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1602 holding.
  • Citigroup first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Citigroup's Medline Inc position peaked at $13.8M in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.